GTR 102831173
Bids Are Invited For Insulin Aspart 100 Ui/Ml (3 Ml), Rituximab 500 Mg Injectable Solution 50 Ml And Others - Mj - Rp
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
102831173
Tendering Authority
Subscribe to view
Tender No
PMJ-2025-164-14/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Insulin Aspart 100 Ui/Ml (3 Ml), Rituximab 500 Mg Injectable Solution 50 Ml And Others - Mj - Rp
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
16-10-2025
Closed
Work Detail
Main Quota - Cumarina 15 Mg + Troxerruit 90 Mg Prolonged Liberation, Reserved Quota - Cumarina 15 Mg + Troxerrinte 90 Mg Prolonged Liberation, Main Quota - Glycosamine Sulfate 1, 5 + Condroitin 1, 2 G, Saches, Reserved Quota - Glycosamine Sulfate 1, Main Quota - Aspart 100 Ui/Ml (3 Ml), 03/10/2025, Reserved Quota - Insulin Aspart 100 Ui/Ml (3 Ml), Main Quota - Insulin Aspart 100 Ui/Ml (10 Ml), Reserved Quota - Insulin Aspart 100 Ui/Ml (10 Ml), Main Quota - Insulin Aspart 100 Ui/Ml 3Ml In Disbelief, Reserved Quota - Aspart 100 Ui/Ml 3Ml In Dispute Injector Pen, Main Quota - Rituximab 500Mg Injectable Solution 50Ml, Reserved Quota - Rituximab 500Mg Injectable Solution 50Ml, Main Quota - Lysine 125Mg, Reserved Quota 125Mg, Main Quota - Diosmin 900Mg + Hesperidine 100Mg In Po - Sachet, Reserved Quota - Reserved - Reserved Quota - Diosmine 900Mg + Hesperidine 100Mg In Po - Saches, Main Quota - Valsartan 320Mg + Hydrochlorothiazide 12, 5Mg, Reserved Quota - Valsartan 320Mg + Hydrochlorothiazide 12, Main Quota - Pegvismento 15Mg Po Liophilo + Diluent, Reserved Quote - Pegvismento 15Mg Po Injectable Lyophilo + Diluent, Main Quota - Somatropin 36Ui Go Quick Pen, Reserved Quota - Somatropin 36Ui Go Quick Pen, Main Quota - Tofacitinib Citrate 5Mg Coated Tablets, Reserved Quota - Tofacitinib Citrate 5Mg Coated Tablets, Main Quota 10Ml (100Mg), Reserved Quota - Nolutionary 10Mg/Ml Ampoule Flask Containing 10Ml (100Mg), Main Quota - Thermiparatic 250 Mcg/Ml Injector Pen 2, 4 Ml, Reserved Quota - Thermiparated 250 Mcg/Ml Injector Pen 2, Main Quota - Insulin Swaludeca 100 Iu/Ml + Liraglitido 3, 3, 6 Mg/Ml, Reserved Quota - Insulin Swaludeca 100 Iu/Ml + Liraglutide 3, Main Quota - Insulin Glargine 100 Ui/Ml + Lixisenatized 50 Mcg/Ml Solution, Reserved Quota - Glargine Insulin 100 Iu/Ml + Sandy 50 Mcg/Ml Solution, Main Quota - Paliperidano Palmitate 200Mg/Ml 1, 315 Ml (263 Mg), Reserved Quota - Paliperidone Palmitate 200Mg/Ml With 1, Main Quota - Insulin Glargine 100U/Ml + Lixisenatide 33Mcg/Ml Sol.Inject, Reserved Quota - Insulin Glargine 100U/Ml + Lixisenatide 33Mcg/Ml Sol.Inject, Main Quota Injectable 100Mg/Ml Applicator Pen, Reserved Quota - Mepolizumab Injectable Solution 100Mg/Ml Applicator
Key Value
Tender Value
54,861 - BRL
Tender Documents
Global Tender Document
2e42821f-b020-49de-8aa3-1b1525acd621.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.